A study of several treatments for new and returning glioblastoma
Original title: A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage study, so it is still being tested in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study looks at more than one treatment for a brain tumor called glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary.
Who this trial is for. This study is for adults with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, both people who were just diagnosed and people whose tumor has come back. It is built to test more than one treatment at the same time, and it runs at sites in many countries.
Where it stands. This study has not reported results. It is still testing whether these treatments help people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. The source does not say what has been measured so far. The answers are not in yet.
What this means, and what it doesn't
What it could mean: Right now this is a study, not care your own doctor can give you. If this sounds like it might fit your situation, you can ask your care team about it. They can tell you if it makes sense for you and what would be involved.
What it doesn't mean: This does not mean these treatments work. A trial is a test, not a proven treatment. Joining a study is not a guarantee that you will be helped. It is not a promise of a cure. It also does not mean a spot is open for you. The study team decides who can join.
Source: ClinicalTrials.gov, July 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.